The Omnipod 5 will be immediately available for people ages 6 to 70. A new technology for people with Type 1 diabetes, one that has been nearly a decade in the making, has been approved by the U.S.

A new automated insulin pump designed by Deka Research & Development and powered by Tidepool’s data and dosing platform has cleared the FDA and is now on its way to support children and adults with ...

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...

AdvaMed supported changes made from a draft version but still has concerns about the impact on patient access.